Related Experiment Video
Updated: Jun 4, 2026
08:27
Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
Genome-wide association studies in atherosclerosis
S Sivapalaratnam1, M M Motazacker, S Maiwald
1Department of Vascular Medicine, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.
Current Atherosclerosis Reports
|March 4, 2011
Summary
Genetic factors significantly influence cardiovascular disease risk. Recent genome-wide studies identified 17 new susceptibility loci for coronary artery disease, advancing our understanding of its complex genetic underpinnings.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Genomics
Background:
- Cardiovascular disease (CVD) is a leading global cause of death.
- CVD pathogenesis is complex and multifactorial.
- A significant heritable component suggests a strong genetic influence on CVD.
Purpose of the Study:
- To review recently identified genetic susceptibility loci for coronary artery disease (CAD).
- To discuss the biological and clinical implications of these genetic discoveries.
- To provide an outlook on human genetics with next-generation sequencing technologies.
Main Methods:
- Genome-wide association studies (GWAS) were utilized.
- Analysis focused on identifying genetic variants associated with CAD.
- Review of recent literature on identified susceptibility loci.
Main Results:
- Seventeen novel susceptibility loci for coronary artery disease have been identified.
- These findings contribute to understanding the genetic architecture of CAD.
- The identified loci offer insights into molecular mechanisms.
Conclusions:
- Genetic factors play a crucial role in the heritability of cardiovascular disease.
- Discoveries enhance understanding of CAD biology and potential clinical applications.
- Future human genetics research will be shaped by next-generation sequencing.
More Related Videos
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...